Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports AusVaxSafety will begin routine safety monitoring of the 2026 seasonal influenza vaccines for all age groups as soon as the vaccines become available in Australia.2026 influenza vaccines used in AustraliaStandard inactivated (injectable) influenza vaccinesFlucelvax (individuals aged 6 months and older)Fluzone (individuals aged 6 months and older)Influvac (individuals aged 6 months and older)Vaxigrip (individuals aged 6 months and older)Adjuvanted or high-dose inactivated (injectable) influenza vaccines Fluad (individuals aged 50 years and older)Fluzone High-Dose (individuals aged 60 years and over)Intranasal live attenuated (nasal spray) influenza vaccine FluMist (individuals aged 2 years to less than 18 years)Statement on the Administration of Seasonal Influenza Vaccines in 2026 – Australian Technical Advisory Group on ImmunisationInfluenza vaccines frequently asked questions – National Centre for Immunisation Research and SurveillanceHow AusVaxSafety monitors influenza vaccine safetyAusVaxSafety collects vaccine safety data using vaccine safety surveys sent to influenza vaccine recipients in the days following their vaccination. Once monitoring begins, safety data for the 2026 influenza vaccines will be updated monthly throughout the influenza season. Previous influenza vaccine safety dataAusVaxSafety influenza vaccine safety data from the 2025 influenza season are available below. Latest influenza vaccine safety dataClick on the tiles below to view 2025 AusVaxSafety influenza vaccine safety data for specific age and population groups. Influenza vaccine safety data – 6 months to younger than 5 years View the latest safety data here Influenza vaccine safety data – 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data – 60 years and older (adjuvanted or high-dose vaccine) View the latest safety data here Influenza vaccine safety data – pregnant participants View the latest safety data here Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages) View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high-dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants (all ages) Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports News & events All news & events 14 April 2026 | News AusVaxSafety begins surveillance of 2026 influenza vaccines, including new nasal spray option 05 March 2026 | News New LP.8.1 COVID-19 vaccines well tolerated, new AusVaxSafety data show 14 July 2025 | News Fewer adverse events reported following NIP pneumococcal vaccine change 03 June 2025 | News New AusVaxSafety data confirms Abrysvo RSV vaccine is well tolerated during pregnancy; adverse events comparable to other maternal vaccinations